Cargando…
Prospective association of serum adipocyte fatty acid‐binding protein with heart failure hospitalization in diabetes
AIMS: Adipocyte fatty acid‐binding protein (AFABP) is associated with cardiovascular diseases in type 2 diabetes. Whether circulating AFABP levels are associated with the risk of heart failure (HF) in type 2 diabetes remains undefined. We investigated the prospective association of circulating AFABP...
Autores principales: | Lee, Chi Ho, Kan, Andy Ka Chun, Lui, David Tak Wai, Fong, Carol Ho Yi, Chan, Darren Shing Hei, Yuen, Michele Mae Ann, Chow, Wing Sun, Woo, Yu Cho, Xu, Aimin, Lam, Karen Siu Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497330/ https://www.ncbi.nlm.nih.gov/pubmed/34355511 http://dx.doi.org/10.1002/ehf2.13472 |
Ejemplares similares
-
Elevated Circulating Adipocyte‐Fatty Acid Binding Protein Levels Predict Incident Cardiovascular Events in a Community‐Based Cohort: A 12‐Year Prospective Study
por: Chow, Wing Sun, et al.
Publicado: (2013) -
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
por: Lee, Chi Ho, et al.
Publicado: (2017) -
Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023) -
A territory‐wide study on the impact of COVID‐19 on diabetes‐related acute care
por: Lui, David Tak Wai, et al.
Publicado: (2020) -
PSUN156 Circulating thrombospondin-2 level as a novel biomarker of heart failure in type 2 diabetes
por: Lee, Chi-Ho, et al.
Publicado: (2022)